The role of cyclooxygenases and prostanoid receptorsin furosemide-like salt losing tubulopathy: the hyperprostaglandin E syndrome
- PMID: 15283766
- DOI: 10.1111/j.1365-201X.2004.01326.x
The role of cyclooxygenases and prostanoid receptorsin furosemide-like salt losing tubulopathy: the hyperprostaglandin E syndrome
Abstract
Hyperprostaglandin E syndrome/antenatal Bartter syndrome is characterized by NaCl wasting and volume depletion, juxtaglomerula hypertrophy, hyperreninism and secondary hyperaldosteronism. Primary causes are mutations in the gene for Na-K-2Cl-cotransporter, NKCC2, or for potassium channel, ROMK, responsible for medullary NaCl malabsorption. Most intriguing aspect of the syndrome is the association with a massively increased renal prostaglandin production which contributes substantially to the clinical picture of the patients. Therefore the term hyperprostaglandin E syndrome has been introduced. It is unclear how prostaglandins aggravate the NaCl transport deficiency. Aspects to prostaglandin synthesis and receptor-mediated function within the kidney in patients suffering from hyperprostaglandin E syndrome/antenatal Bartter syndrome will be discussed.
Similar articles
-
Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.J Am Soc Nephrol. 2005 Aug;16(8):2354-62. doi: 10.1681/ASN.2004070556. Epub 2005 Jun 23. J Am Soc Nephrol. 2005. PMID: 15976003
-
Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide.Clin Pharmacol Ther. 2001 Oct;70(4):384-90. Clin Pharmacol Ther. 2001. PMID: 11673754 Clinical Trial.
-
Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome.Kidney Int. 2002 Jul;62(1):253-60. doi: 10.1046/j.1523-1755.2002.00435.x. Kidney Int. 2002. PMID: 12081585
-
Pharmacotyping of hypokalaemic salt-losing tubular disorders.Acta Physiol Scand. 2004 Aug;181(4):513-21. doi: 10.1111/j.1365-201X.2004.01325.x. Acta Physiol Scand. 2004. PMID: 15283765 Review.
-
An improved terminology and classification of Bartter-like syndromes.Nat Clin Pract Nephrol. 2008 Oct;4(10):560-7. doi: 10.1038/ncpneph0912. Epub 2008 Aug 12. Nat Clin Pract Nephrol. 2008. PMID: 18695706 Review.
Cited by
-
Female ROMK null mice manifest more severe Bartter II phenotype on renal function and higher PGE2 production.Am J Physiol Regul Integr Comp Physiol. 2008 Sep;295(3):R997-R1004. doi: 10.1152/ajpregu.00051.2007. Epub 2008 Jun 25. Am J Physiol Regul Integr Comp Physiol. 2008. PMID: 18579648 Free PMC article.
-
Flexible and multifaceted: the plasticity of renin-expressing cells.Pflugers Arch. 2022 Aug;474(8):799-812. doi: 10.1007/s00424-022-02694-8. Epub 2022 May 5. Pflugers Arch. 2022. PMID: 35511367 Free PMC article. Review.
-
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.Pediatr Nephrol. 2011 Oct;26(10):1789-802. doi: 10.1007/s00467-011-1871-4. Epub 2011 Apr 19. Pediatr Nephrol. 2011. PMID: 21503667 Free PMC article. Review.
-
Effects of lipids on ENaC activity in cultured mouse cortical collecting duct cells.J Membr Biol. 2009 Jan;227(2):77-85. doi: 10.1007/s00232-008-9145-1. Epub 2009 Jan 3. J Membr Biol. 2009. PMID: 19122972
-
Biomechanical regulation of cyclooxygenase-2 in the renal collecting duct.Am J Physiol Renal Physiol. 2014 Jan;306(2):F214-23. doi: 10.1152/ajprenal.00327.2013. Epub 2013 Nov 13. Am J Physiol Renal Physiol. 2014. PMID: 24226521 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources